Puzzlingly, semaglutide (the active ingredient in Ozempic) has been FDA approved for weight loss under the brand name Wegovy
Cardiovascular Outcomes DPP-4 Inhibitors Five trials enrolling almost 50,000 patients have evaluated the cardiovascular safety of DPP-4 inhibitors
For instance, people with a history of thyroid cancer or certain thyroid diseases, pancreatitis, or kidney disease may be advised against using it
Through ongoing research and advancements in the field, the effectiveness and understanding of these interventions continue to evolve, offering hope and potential improvements for individuals with ASD
Individuals with compromised immune systemsincluding those undergoing chemotherapy, taking immunosuppressive medications, or living with HIV/AIDSface a small but significant risk of probiotic-related infections